Robot-assisted knee replacement surgery is more precise than a surgeon on their own, but does not currently lead to improvements in patient outcomes, according to the RACER-Knee trial,… read more.
Automatic crash notification (ACN) systems should become a standard safety feature in every new vehicle, like seat belts and air bags, according to a new paper by members of the American… read more.
NICE(UK) is unable to make a recommendation about the use in the NHS of brensocatib for treating non-cystic fibrosis bronchiectasis in people 12 years and over. This is because… read more.
Eli Lilly and Company announced that the FDA approved Mounjaro (tirzepatide), a dual GIP and GLP-1 hormone receptor agonist, to lower the risk of major adverse cardiovascular (CV)… read more.
A deep-learning tool developed to analyze sinus CT scans may provide a more sensitive way to detect treatment-related changes in patients with chronic rhinosinusitis with nasal polyps, according… read more.
The United Kingdom’s vote to leave the European Union (EU) was associated with major changes in health care worker migration and worsening physician shortages in England, according to… read more.
Pfizer Inc. and BioNTech SE announced that the FDA has approved the supplemental Biologics License Application (sBLA) for the companies’ 2026-2027 COVID-19 vaccine formula targeting the XFG variant… read more.
The National Institute for Health and Care Excellence (NICE) has issued nine Technology Appraisal decisions in August 2026, comprising five positive first recommendations, one updated positive recommendation, and… read more.
Women have driven the expansion of the global health workforce over the past three decades, yet substantial workforce shortages remain, according to a new study published in The Lancet Public… read more.
GE HealthCare recently achieved CE Mark for Photonova Spectra, an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon detector technology. The regulatory milestone expands… read more.
Quest Diagnostics announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, with the goal of broadening access to quality blood tests… read more.
You get a message that a test result is available in your online patient portal. Do you look at it right away, or do you wait to hear… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
